These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 17465729)
1. Regenerative medicine bioprocessing: the need to learn from the experience of other fields. Mason C; Hoare M Regen Med; 2006 Sep; 1(5):615-23. PubMed ID: 17465729 [No Abstract] [Full Text] [Related]
2. The need for a regen industry voice. Mason C; Dunnill P Regen Med; 2008 Sep; 3(5):621-31. PubMed ID: 18729785 [No Abstract] [Full Text] [Related]
3. Regenerative medicine bioprocessing: building a conceptual framework based on early studies. Mason C; Hoare M Tissue Eng; 2007 Feb; 13(2):301-11. PubMed ID: 17518564 [TBL] [Abstract][Full Text] [Related]
4. Regenerative medicine and the developing world. Greenwood HL; Singer PA; Downey GP; Martin DK; Thorsteinsdóttir H; Daar AS PLoS Med; 2006 Sep; 3(9):e381. PubMed ID: 16968130 [TBL] [Abstract][Full Text] [Related]
5. Tissue engineering and regenerative science in pediatrics. Dunn JC Pediatr Res; 2008 May; 63(5):459-60. PubMed ID: 18360308 [No Abstract] [Full Text] [Related]
7. Therapeutic cell delivery for in situ regenerative medicine. Wang DA; Mahato RI Adv Drug Deliv Rev; 2010 Jun; 62(7-8):669-70. PubMed ID: 20420868 [No Abstract] [Full Text] [Related]
9. Bio-electrosprays: the development of a promising tool for regenerative and therapeutic medicine. Jayasinghe SN Biotechnol J; 2007 Aug; 2(8):934-7. PubMed ID: 17582825 [TBL] [Abstract][Full Text] [Related]
10. Potential of endogenous regenerative technology for in situ regenerative medicine. Anitua E; Sánchez M; Orive G Adv Drug Deliv Rev; 2010 Jun; 62(7-8):741-52. PubMed ID: 20102730 [TBL] [Abstract][Full Text] [Related]
11. [Regenerative medicine for rheumatoid arthritis--current status and problems]. Adachi N; Ochi M Nihon Rinsho; 2005 Jan; 63 Suppl 1():666-71. PubMed ID: 15799439 [No Abstract] [Full Text] [Related]
13. Genetically modified cells in regenerative medicine and tissue engineering. Sheyn D; Mizrahi O; Benjamin S; Gazit Z; Pelled G; Gazit D Adv Drug Deliv Rev; 2010 Jun; 62(7-8):683-98. PubMed ID: 20114067 [TBL] [Abstract][Full Text] [Related]
14. Scaffold-free cell delivery for use in regenerative medicine. Kelm JM; Fussenegger M Adv Drug Deliv Rev; 2010 Jun; 62(7-8):753-64. PubMed ID: 20153387 [TBL] [Abstract][Full Text] [Related]
15. [Current regenerative therapy for the cornea]. Nakamura T; Kinoshita S Nihon Rinsho; 2008 May; 66(5):955-60. PubMed ID: 18464516 [TBL] [Abstract][Full Text] [Related]
16. [The industrialization of regenerative medicine--a potential market of $ 500 billion]. Gu Q; Zhang X; Jiang L Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Sep; 21(9):1011-5. PubMed ID: 17933243 [TBL] [Abstract][Full Text] [Related]
17. Tissue engineering and regenerative medicine: manufacturing challenges. Williams DJ; Sebastine IM IEE Proc Nanobiotechnol; 2005 Dec; 152(6):207-10. PubMed ID: 16441181 [TBL] [Abstract][Full Text] [Related]
18. Regenerative medicine: a primer for paediatricians. Polak DJ Early Hum Dev; 2009 Nov; 85(11):685-9. PubMed ID: 19783108 [TBL] [Abstract][Full Text] [Related]
19. Studies on regenerative medicine in Japan. Kuroyanagi Y Artif Organs; 2004 Jan; 28(1):11-2. PubMed ID: 14720282 [No Abstract] [Full Text] [Related]
20. Tissue engineering and regenerative medicine: role of toxicologic pathologists for an emerging medical technology. Jayo MJ; Watson DD; Wagner BJ; Bertram TA Toxicol Pathol; 2008 Jan; 36(1):92-6. PubMed ID: 18337226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]